Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,341
Total Claims
$360K
Drug Cost
487
Beneficiaries
$739
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+442%
Opioid rate vs peers
49.8% vs 9.2% avg
+3%
Cost per patient vs peers
$739 vs $719 avg
-61%
Brand preference vs peers
2.6% vs 6.7% avg
🔎 Data Overview
Opioid rate is 442% above Physician Assistant peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
49.8%
Opioid Rate
4,650
Opioid Claims
$216K
Opioid Cost
4.5%
Long-Acting Rate
This provider's opioid prescribing rate of 49.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 240 claims · $110K
Generic: 9,101 claims · $250K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 1,832 | $56K |
| Oxycodone Hcl | 1,474 | $39K |
| Oxycodone Myristate | 41 | $35K |
| Oxycodone Hcl/Acetaminophen | 886 | $33K |
| Gabapentin | 1,430 | $29K |
| Pregabalin | 386 | $22K |
| Buprenorphine Hcl | 15 | $16K |
| Naloxone Hcl | 176 | $15K |
| Buprenorphine | 13 | $14K |
| Linaclotide | 20 | $11K |
| Buprenorphine | 20 | $8,108 |
| Tapentadol Hcl | 11 | $6,419 |
| Lidocaine | 66 | $5,606 |
| Orphenadrine Citrate | 75 | $5,488 |
| Celecoxib | 103 | $4,836 |
Prescribing Profile
49
Unique Drugs
26.0
Anomaly Score
Patient Profile
66
Avg Age
54%
Female
1.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data